Holen Sie sich die Stockscreener-App
1.27
2.31%
-0.03
Schlusskurs vom Vortag:
$1.30
Offen:
$1.3
24-Stunden-Volumen:
843.17K
Relative Volume:
0.57
Marktkapitalisierung:
$92.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-44.95M
KGV:
-1.423
EPS:
-0.8925
Netto-Cashflow:
$-56.37M
1W Leistung:
-3.79%
1M Leistung:
-34.37%
6M Leistung:
-17.53%
1J Leistung:
-40.38%
1-Tages-Spanne:
$1.26
$1.305
1-Wochen-Bereich:
$1.25
$1.37
52-Wochen-Spanne:
$0.8719
$2.99
Biomea Fusion Inc Stock (BMEA) Company Profile
Firmenname
Biomea Fusion Inc
Sektor
Branche
Telefon
(650) 980-9099
Adresse
1599 INDUSTRIAL ROAD, SAN CARLOS
Compare BMEA vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
1.27 | 95.68M | 0 | -44.95M | -56.37M | -0.8925 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2025-08-28 | Eingeleitet | Jefferies | Buy |
| 2025-06-03 | Fortgesetzt | Piper Sandler | Overweight |
| 2024-10-09 | Eingeleitet | Edward Jones | Buy |
| 2024-09-27 | Hochstufung | Rodman & Renshaw | Neutral → Buy |
| 2024-09-27 | Hochstufung | Truist | Hold → Buy |
| 2024-08-29 | Eingeleitet | CapitalOne | Overweight |
| 2024-06-11 | Herabstufung | Truist | Buy → Hold |
| 2024-06-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-04-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-06 | Eingeleitet | Truist | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-12 | Eingeleitet | Barclays | Overweight |
| 2023-03-29 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-28 | Bestätigt | H.C. Wainwright | Buy |
| 2023-02-24 | Eingeleitet | Citigroup | Buy |
| 2022-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-01-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-17 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-11 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-11 | Eingeleitet | Jefferies | Buy |
| 2021-05-11 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Biomea Fusion Inc Aktie (BMEA) Neueste Nachrichten
Biomea Fusion, Inc. (BMEA) Options Chain - Yahoo! Finance Canada
Citizens reiterates Biomea Fusion stock rating on menin inhibitor validation - Investing.com
BMEA Stock Slides As Biomea Fusion Pulls Equity Offering - timothysykes.com
Form 424B5 Biomea Fusion Inc For: 27 September By Investing.com - Investing.com Nigeria
Biomea Fusion Shares Fall 19% After Hours: Here’s Why - webull.com
Biomea Fusion scraps equity offering, delays study data - scanx.trade
Biomea Pulls Equity Raise, Trading Dilution Relief For Near-Term Runway Pressure (BMEA) - Seeking Alpha
Biomea Fusion Scraps Stock Offering, Sending Shares Down 19% After Hours - finance.biggo.com
Biomea Fusion Shares Fall After Terminating Proposed Public Offering - marketscreener.com
Bearish Sentiment: Biomea Fusion Scraps Equity Offering, Delays Study Data - Benzinga
Biomea Fusion Completes Phase 1 BMF-500 Trial in Acute Leukemia: What Investors Should Watch Next - TipRanks
Biomea stock slips after delaying trial readout (BMEA:NASDAQ) - Seeking Alpha
Biomea Fusion stock ticks up after canceling public offering By Investing.com - Investing.com South Africa
Biomea Fusion stock ticks up after canceling public offering - Investing.com
Biomea Fusion Announces Termination of Proposed Public Offering of Securities - Investing News Network
Biomea Fusion terminates proposed public offering By Investing.com - Investing.com Canada
Biomea Fusion terminates proposed public offering - Investing.com
Biomea Fusion Announces Termination Of Proposed Public Offering Of Securities - TradingView
Biomea Fusion stock tumbles on public offering launch - Investing.com
Biomea Fusion stock tumbles on public offering launch By Investing.com - Investing.com Nigeria
Biomea Fusion Updates Timeline for BMF-650 Phase I Data - TipRanks
Biomea Fusion announces public offering of common stock - Investing.com
Biomea Fusion announces public offering of common stock By Investing.com - Investing.com Nigeria
Biomea Fusion Proposes Public Offering of Common Stock, Pre-Funded Warrants - marketscreener.com
Biomea Fusion Announces Proposed Public Offering of Securities - The Manila Times
Biomea Fusion announces proposed public offering of shares - TradingView
No size or terms are set for Biomea Fusion's share offering. Its underwriter may buy up to 15% more. - Stock Titan
BMEA Stock Price and Chart — NASDAQ:BMEA - TradingView
Biomea Fusion, Inc.(NasdaqGS: BMEA) dropped from S&P Global BMI Index - marketscreener.com
Biomea Fusion Q2 2026 Earnings: Narrower-Than-Expected Loss Drives Modest Stock GainRevenue Recognition Risk - dars.gov.et
Biomea Fusion, Inc. (BMEA) Presents at H.C. Wainwright 28th Annual Global Investment ConferenceSlideshow (NASDAQ:BMEA) 2026-09-16 - Seeking Alpha
After Golden Cross, Biomea Fusion, Inc. (BMEA)'s Technical Outlook is Bright - Yahoo Finance
Biomea Fusion Completes Key Phase 2 Trial in Type 1 Diabetes: What Investors Should Watch Next - TipRanks
Biomea Fusion to Participate in Upcoming Investor Conferences - Investing News Network
BMEA Surges 6.85%: Biomea Fusion Approaches Key $1.88 ResistanceQuote Data - vinanet.vn
BMEA Should I Buy - Intellectia AI
Biomea Fusion Inc (BMEA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com
Here's Why We're Watching Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation - Sahm
Biomea Shares Rise After Completing Enrollment in Diabetes Trial - marketscreener.com
Biomea Fusion stock surges on diabetes trial enrollment completion By Investing.com - Investing.com Canada
H.C. Wainwright reiterates Biomea Fusion stock rating on trial enrollment By Investing.com - Investing.com UK
Why is Biomea Fusion stock climbing today? By Investing.com - Investing.com India
Biomea Fusion completes enrollment in diabetes trial By Investing.com - Investing.com Canada
Biomea Fusion Announces Completion Of Enrollment In Covalent-211 Phase Ii Trial Of Icovamenib In Insulin-Deficient Type 2 Diabetes - TradingView
Citi sees up to 410% upside in 2 biotech stocks: is the risk worth it? - TradingView
Biomea (BMEA) Quarterly Results: Profit Per Share Clears Its Benchmark at the Close; Investor Response - vinanet.vn
Biomea Fusion begins dosing first participant in OPAL study arm for new combination therapy - Traders Union
Biomea Fusion (NASDAQ:BMEA) Gains Attention As Institutions Expand Exposure - Kalkine Media
Finanzdaten der Biomea Fusion Inc-Aktie (BMEA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Biomea Fusion Inc-Aktie (BMEA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hitchcock Michael J.M. | Interim CEO |
Dec 02 '25 |
Buy |
0.99 |
100,000 |
99,180 |
115,000 |
| Erdtmann Rainer M | See Remarks |
Nov 28 '25 |
Buy |
1.10 |
40,000 |
44,052 |
683,027 |
| Erdtmann Rainer M | See Remarks |
Dec 01 '25 |
Buy |
1.05 |
10,000 |
10,500 |
693,027 |
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):